Tambocor

Tambocor

flecainide

Manufacturer:

iNova

Distributor:

Zuellig
/
Agencia Lei Va Hong
Concise Prescribing Info
Contents
Flecainide acetate
Indications/Uses
AV nodal reciprocating tachycardia; Wolff-Parkinson-White syndrome & similar conditions w/ accessory pathways. Paroxysmal atrial fibrillation in patients w/ disabling symptoms. Symptomatic sustained ventricular tachycardia. Premature ventricular contractions &/or non-sustained ventricular tachycardia which are causing disabling symptoms, where these are resistant to other therapy or when other treatment has not been tolerated.
Dosage/Direction for Use
Adult Supraventricular arrhythmias Initially 50 mg bd. Max: 300 mg/day. Ventricular arrhythmias Initially: 100 mg bd. Max: 400 mg/day.
Administration
May be taken with or without food.
Contraindications
Cardiac failure, patient w/ history of MI who has either asymptomatic ventricular ectopics or nonsustained ventricular tachycardia. Long-standing atrial fibrillation w/ no attempt to convert to sinus rhythm, haemodynamically significant valvular heart disease. Sinus nodal dysfunction, atrial conduction defects, 2nd degree or greater AV block, bundle branch block or distal block unless pacing rescue available.
Special Precautions
Correct electrolyte disturbances before instituting therapy. Significant hepatic impairment, patient w/ permanent pacemakers or temporary pacing electrodes; predisposition to cardiac failure. Patient w/ acute onset of atrial fibrillation following cardiac surgery. Plasma monitoring in patient w/ significant renal impairment. Pregnancy. Childn <12 yr. Elderly.
Adverse Reactions
Most commonly, giddiness, dizziness, lightheadedness, visual disturbances, nausea & vomiting. Proarrhythmia may occur in patients w/ structural heart disease &/or significant left ventricular impairment.
Drug Interactions
Avoid use w/ other Na channel blockers. May cause rise in plasma digoxin. Possible additive negative inotropic effects of β-blockers & other cardiac depressants. Enzyme inducers enhance elimination. Reduce flecainide dosage by 50% when given in the presence of amiodarone.
MIMS Class
ATC Classification
C01BC04 - flecainide ; Belongs to class Ic antiarrhythmics.
Presentation/Packing
Form
Tambocor tab 100 mg
Packing/Price
60's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in